Utah Medical Products Return on Tangible Equity 2010-2025 | UTMD

Current and historical return on tangible equity values for Utah Medical Products (UTMD) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Utah Medical Products Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.01B $0.10B 12.50%
2024-12-31 $0.01B $0.10B 13.18%
2024-09-30 $0.02B $0.11B 13.82%
2024-06-30 $0.02B $0.11B 13.89%
2024-03-31 $0.02B $0.11B 15.02%
2023-12-31 $0.02B $0.11B 15.53%
2023-09-30 $0.02B $0.11B 17.30%
2023-06-30 $0.02B $0.10B 18.28%
2023-03-31 $0.02B $0.10B 19.32%
2022-12-31 $0.02B $0.09B 20.24%
2022-09-30 $0.02B $0.08B 20.00%
2022-06-30 $0.02B $0.08B 20.45%
2022-03-31 $0.02B $0.08B 19.74%
2021-12-31 $0.01B $0.08B 19.18%
2021-09-30 $0.01B $0.08B 18.44%
2021-06-30 $0.01B $0.07B 18.11%
2021-03-31 $0.01B $0.07B 16.06%
2020-12-31 $0.01B $0.07B 17.09%
2020-09-30 $0.01B $0.06B 19.47%
2020-06-30 $0.01B $0.06B 22.12%
2020-03-31 $0.02B $0.05B 28.85%
2019-12-31 $0.02B $0.06B 30.30%
2019-09-30 $0.01B $0.05B 27.86%
2019-06-30 $0.02B $0.05B 32.54%
2019-03-31 $0.02B $0.04B 31.63%
2018-12-31 $0.02B $0.06B 32.43%
2018-09-30 $0.01B $0.06B 23.08%
2018-06-30 $0.01B $0.05B 18.18%
2018-03-31 $0.01B $0.05B 18.95%
2017-12-31 $0.01B $0.05B 19.89%
2017-09-30 $0.02B $0.05B 34.88%
2017-06-30 $0.01B $0.05B 34.57%
2017-03-31 $0.01B $0.04B 33.99%
2016-12-31 $0.01B $0.04B 32.88%
2016-09-30 $0.01B $0.04B 34.29%
2016-06-30 $0.01B $0.04B 37.21%
2016-03-31 $0.01B $0.03B 40.34%
2015-12-31 $0.01B $0.03B 44.44%
2015-09-30 $0.01B $0.03B 48.98%
2015-06-30 $0.01B $0.03B 53.93%
2015-03-31 $0.01B $0.02B 60.00%
2014-12-31 $0.01B $0.02B 66.67%
2014-09-30 $0.01B $0.02B 76.19%
2014-06-30 $0.01B $0.02B 90.57%
2014-03-31 $0.01B $0.02B 111.63%
2013-12-31 $0.01B $0.01B 150.00%
2013-09-30 $0.01B $0.01B 209.52%
2013-06-30 $0.01B $0.01B 440.00%
2013-03-31 $0.01B $0.00B -4000.00%
2012-12-31 $0.01B $0.00B -333.33%
2012-09-30 $0.01B $0.00B -173.91%
2012-06-30 $0.01B $0.00B -109.09%
2012-03-31 $0.01B $-0.01B -83.72%
2011-12-31 $0.01B $-0.01B -53.85%
2011-09-30 $0.01B $-0.01B -233.33%
2011-06-30 $0.01B $-0.01B 87.50%
2011-03-31 $0.01B $-0.02B 30.77%
2010-12-31 $0.01B $0.03B 22.40%
2010-09-30 $0.01B $0.03B 22.22%
2010-06-30 $0.01B $0.03B 22.58%
2010-03-31 $0.01B $0.03B 26.45%
2009-12-31 $0.01B $0.03B 27.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.182B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.034B 28.02
Boston Scientific (BSX) United States $152.131B 38.08
Stryker (SYK) United States $146.225B 30.58
EssilorLuxottica (ESLOY) France $128.281B 0.00
Medtronic (MDT) Ireland $111.581B 15.82
Haleon (HLN) United Kingdom $50.069B 28.51
Lonza Group Ag (LZAGY) Switzerland $49.244B 0.00
ResMed (RMD) United States $36.611B 27.50
GE HealthCare Technologies (GEHC) United States $32.762B 15.55
Agilent Technologies (A) United States $32.366B 21.10
Terumo (TRUMY) Japan $26.576B 34.52
Insulet (PODD) United States $22.320B 87.61
Koninklijke Philips (PHG) Netherlands $21.929B 15.76
Zimmer Biomet Holdings (ZBH) United States $18.186B 11.68
Baxter (BAX) United States $15.472B 11.55
Smith & Nephew SNATS (SNN) United Kingdom $13.270B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.449B 0.00
Bio-Rad Laboratories (BIO) United States $5.968B 20.77
Lantheus Holdings (LNTH) United States $5.558B 14.02
Prestige Consumer Healthcare (PBH) United States $4.181B 18.68
Perrigo (PRGO) Ireland $3.570B 9.05
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.382B 15.40
ICU Medical (ICUI) United States $3.271B 24.12
Envista Holdings (NVST) United States $3.166B 26.31
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.022B 13.91
LeMaitre Vascular (LMAT) United States $1.884B 42.12
AtriCure (ATRC) United States $1.726B 0.00
Acuren (TIC) United States $1.272B 0.00
AdaptHealth (AHCO) United States $1.217B 12.36
Green Thumb Industries (GTBIF) United States $1.080B 24.29
Neogen (NEOG) United States $1.066B 13.64
Kestra Medical Technologies (KMTS) United States $1.025B 0.00
BioLife Solutions (BLFS) United States $1.021B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.38
InMode (INMD) Israel $0.906B 9.13
CeriBell (CBLL) United States $0.633B 0.00
Evolus (EOLS) United States $0.628B 0.00
Capricor Therapeutics (CAPR) United States $0.602B 0.00
Owens & Minor (OMI) United States $0.588B 4.88
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.553B 0.00
Valneva SE (VALN) France $0.525B 0.00
Surmodics (SRDX) United States $0.426B 0.00
Tilray Brands (TLRY) Canada $0.391B 0.00
VAREX IMAGING (VREX) United States $0.345B 12.68
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.304B 54.10
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.264B 0.00
Viemed Healthcare (VMD) United States $0.260B 21.97
Cresco Labs (CRLBF) United States $0.260B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
ZimVie (ZIMV) United States $0.254B 11.54
Canopy Growth (CGC) Canada $0.252B 0.00
Sanuwave Health (SNWV) United States $0.238B 0.00
OraSure Technologies (OSUR) United States $0.210B 0.00
TriSalus Life Sciences (TLSI) United States $0.202B 0.00
Biote (BTMD) United States $0.201B 5.65
Quanterix (QTRX) United States $0.200B 0.00
Brainsway (BWAY) Israel $0.195B 51.55
Omeros (OMER) United States $0.193B 0.00
Verano Holdings (VRNOF) United States $0.191B 0.00
High Tide (HITI) Canada $0.190B 0.00
Organigram Global (OGI) Canada $0.175B 0.00
Exagen (XGN) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.127B 0.00
Jin Medical (ZJYL) China $0.124B 0.00
MacroGenics (MGNX) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.60
Veru (VERU) United States $0.088B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
TerrAscend (TSNDF) Canada $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
Agape ATP (ATPC) $0.073B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.058B 0.00
Modular Medical (MODD) United States $0.044B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.036B 48.57
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.019B 0.00
INLIF (INLF) $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00